|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 18717135.0 (espacenet) (Federated) (European Patent Register), 20180308 | | Patent/reg. no. and date | DK/EP 3592772, 20240320 | | Publication date | 20200115 | | Priority no. and date | IL 25102417, 20170308 | | EP pub. no. and date |
EP 3592772 20200115 | | Effective date | | | Applicant/owner | Chemomab Ltd., Kiryat Aditim Building 7 Entrance B
6158002 Tel Aviv, IL | | Applicant ref. no. | | | Inventor | MOR, Adi, 9 Meizan St.
6901872 Tel Aviv, IL | | Representative | | | Opponent | | | IPC Class | C07K 16/24 (2006.01) | | Title | ANTI CCL24 (EOTAXIN2) ANTIBODIES FOR USE IN THE TREATMENT OF HEPATIC DISEASES | | Int. application no. | IL2018050276 | | Int. publication no. | WO2018163185 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
